APRE
Aprea Therapeutics, Inc.
Company overview
- Market capitalization
- $9.47M
- Employees
- 8
- Latest publication
- 2026-09-29
About Aprea Therapeutics, Inc.
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidates are APR-1051, an orally bioavailable small-molecule inhibitor of WEE1 kinase that is in Phase 1 clinical trial for the treatment of patients with advanced solid tumors with biomarkers and ATRN-119, an ATR inhibitor, which is in Phase 1/2a clinical trial for solid tumor indications. The company is headquartered in Doylestown, Pennsylvania.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 118,111USD | 0USD | 3,337USD | 1,848USD | 118,111USD | 162,463USD | 205,817USD | 354,621USD |
| Research Development | 2,462,042USD | 1,611,167USD | 1,008,839USD | 1,638,917USD | 1,912,213USD | 2,483,066USD | 2,359,086USD | 2,846,399USD |
| Total Operating Expenses | 4,032,180USD | 3,424,984USD | 2,643,093USD | 3,117,388USD | 1,593,671USD | 1,764,978USD | 1,072,776USD | 1,605,238USD |
| Net Income | -3,591,304USD | -3,287,917USD | -2,455,630USD | -2,972,410USD | -3,238,870USD | -3,932,659USD | -2,894,799USD | -3,783,769USD |
| Cost Of Revenue | — | 5,428USD | -4,378,993USD | 5,429USD | 1,912,213USD | 2,483,066USD | 2,359,086USD | 2,846,399USD |
| Gross Profit | — | -5,428USD | 4,382,330USD | -3,581USD | -1,794,102USD | -2,320,603USD | -2,153,269USD | -2,491,778USD |
| Selling General Administrative | — | 1,819,245USD | 1,637,591USD | 1,480,319USD | 1,593,671USD | 1,764,979USD | 1,072,776USD | 1,605,238USD |
| Operating Income | — | -3,430,412USD | -2,643,093USD | -3,117,388USD | -3,387,773USD | -4,085,581USD | -3,226,045USD | -4,097,016USD |
| Interest Income | — | 134,784USD | 118,664USD | 150,669USD | 178,027USD | 204,726USD | 274,626USD | 348,741USD |
| Net Interest Income | — | 134,784USD | 118,664USD | 150,669USD | 178,027USD | 204,726USD | 274,626USD | 348,741USD |
| Income Before Tax | — | -3,287,917USD | -2,455,630USD | -2,972,410USD | -3,238,870USD | -3,932,659USD | -2,894,799USD | -3,783,769USD |
| Net Income From Continuing Ops | — | -3,287,917USD | -2,455,630USD | -2,972,410USD | -3,238,870USD | -3,932,659USD | -2,894,799USD | -3,783,769USD |
| Ebit | — | -3,430,411USD | -2,643,093USD | -3,117,388USD | -3,387,773USD | -4,085,581USD | -3,226,045USD | -4,097,016USD |
| Ebitda | — | -3,424,983USD | -2,637,664USD | -3,111,959USD | -3,382,345USD | -4,080,153USD | -3,220,617USD | -4,091,586USD |
| Depreciation And Amortization | — | 5,428USD | 5,429USD | 5,429USD | 5,428USD | 5,428USD | 5,428USD | 5,430USD |
| Reconciled Depreciation | — | 5,428USD | 5,429USD | 5,429USD | 5,428USD | 5,429USD | 5,428USD | 5,429USD |
| Total Other Income Expense Net | — | 142,495USD | 187,463USD | 144,978USD | 148,903USD | 152,922USD | 331,246USD | 313,247USD |
| Unclassified Operating Expenses | — | — | — | — | -1,912,213USD | -2,483,067USD | -2,359,086USD | -2,846,399USD |
| Income Tax Expense | — | — | — | — | — | — | 3USD | — |
| Source | DisclosurePreliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 285,759USD | 1,502,581USD | 583,231USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 21,715USD | 9,363,537USD | 7,052USD | 16,402,273USD | 271,677USD | 229,610USD | 170,254USD | 8,316USD |
| Gross Profit | 264,044USD | -7,860,956USD | 576,179USD | -16,402,273USD | -271,677USD | -229,610USD | -170,254USD | -8,316USD |
| Research Development | 7,043,035USD | 9,363,537USD | 7,627,491USD | 92,422,457USD | 23,895,875USD | 37,879,325USD | 20,950,672USD | 14,194,732USD |
| Selling General Administrative | 6,476,560USD | 6,458,699USD | 8,427,703USD | 20,969,771USD | 13,550,478USD | 14,931,887USD | 8,593,626USD | 2,294,671USD |
| Total Operating Expenses | 13,233,836USD | 6,458,699USD | 16,048,142USD | 96,989,955USD | 37,174,676USD | 52,811,212USD | 29,374,044USD | 16,489,403USD |
| Operating Income | -13,233,836USD | -14,319,655USD | -15,471,963USD | -113,392,228USD | -37,446,353USD | -52,811,212USD | -29,544,298USD | -16,489,403USD |
| Interest Income | 652,086USD | 1,289,144USD | 1,224,133USD | 448,667USD | 1,648USD | 222,652USD | 1,484,490USD | 961,140USD |
| Net Interest Income | 652,086USD | 1,289,144USD | 1,156,928USD | 448,667USD | 1,648USD | 222,652USD | 156,351USD | -182USD |
| Income Before Tax | -12,599,569USD | -12,958,711USD | -14,286,756USD | -112,662,027USD | -37,127,303USD | -53,478,812USD | -28,059,807USD | -15,528,269USD |
| Net Income | -12,599,569USD | -12,958,711USD | -14,286,756USD | -112,662,027USD | -36,536,576USD | -53,916,802USD | -28,059,807USD | -15,528,269USD |
| Net Income From Continuing Ops | -12,599,569USD | -12,958,711USD | -13,285,644USD | -112,662,027USD | -37,127,303USD | -53,478,812USD | -28,059,807USD | -15,528,269USD |
| Ebit | -13,233,836USD | -14,319,655USD | -14,286,760USD | -37,372,044USD | -37,127,305USD | -53,478,810USD | -28,059,808USD | -15,528,273USD |
| Ebitda | -13,212,121USD | -14,297,337USD | -14,279,708USD | -37,367,641USD | -36,855,628USD | -53,249,200USD | -27,889,554USD | -15,519,957USD |
| Depreciation And Amortization | 21,715USD | 22,318USD | 7,052USD | 4,403USD | 271,677USD | 229,610USD | 170,254USD | 8,316USD |
| Reconciled Depreciation | 21,715USD | 22,318USD | -319USD | 186,445USD | 271,677USD | 229,610USD | 170,254USD | 8,316USD |
| Total Other Income Expense Net | 634,267USD | 1,360,944USD | 1,185,207USD | 730,201USD | 319,050USD | -667,600USD | 1,484,491USD | 961,134USD |
| Unclassified Operating Expenses | — | -9,363,537USD | — | -16,402,273USD | — | — | — | — |
| Selling And Marketing Expenses | — | — | 7,052USD | — | — | — | — | — |
| Income Tax Expense | — | — | -2USD | 112,213,360USD | -590,727USD | 437,990USD | -1,654,745USD | 961,316USD |
| Interest Expense | — | — | — | 448,667USD | 1,648USD | 222,652USD | 156,351USD | 182USD |
| Net Income Applicable To Common Shares | — | — | — | -112,662,027USD | -37,127,303USD | -53,478,812USD | -28,059,807USD | -15,528,269USD |
| Non Operating Income Net Other | — | — | — | — | — | -667,600USD | — | 0USD |
| Minority Interest | — | — | — | — | — | — | — | 0USD |
| Discontinued Operations | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 42,289,924USD | 48,112,386USD | 15,933,401USD | 14,321,316USD | 17,309,710USD | 20,222,083USD | 23,979,493USD | 26,893,969USD |
| Cash And Equivalents | 41,233,428USD | — | — | — | — | — | — | — |
| Total Current Assets | 41,913,114USD | 47,245,440USD | 15,561,246USD | 13,943,988USD | 16,927,210USD | 19,834,410USD | 23,576,139USD | 26,483,820USD |
| Other Current Assets | 679,686USD | 779,238USD | 961,899USD | 225,936USD | 395,011USD | 558,689USD | 726,254USD | 234,195USD |
| Other Non Current Assets | 271,162USD | — | — | — | — | — | — | — |
| Total Liabilities | 3,819,663USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 3,092,302USD | 5,296,646USD | 2,764,358USD | 2,681,107USD | 3,167,668USD | 3,361,098USD | 3,360,975USD | 3,635,888USD |
| Total Stockholder Equity | 38,470,261USD | 42,815,740USD | 12,441,682USD | 11,640,209USD | 13,414,681USD | 15,549,922USD | 19,307,455USD | 21,947,018USD |
| Total Equity Including Noncontrolling Interest | 38,470,261USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 64,033USD | 54,379USD | 59,807USD | 65,236USD | 70,665USD | 76,093USD | 81,522USD | 86,950USD |
| Accounts Payable | 935,139USD | 2,940,756USD | 713,668USD | 641,322USD | 1,195,838USD | 1,281,651USD | 1,352,240USD | 1,153,880USD |
| Common Stock | 12,391USD | 11,983USD | 8,192USD | 5,979USD | 5,752USD | 5,513USD | 5,481USD | 5,435USD |
| Retained Earnings | -340,520,662USD | -336,929,358USD | -333,641,441USD | -331,185,811USD | -328,213,401USD | -324,974,531USD | -321,041,872USD | -318,147,073USD |
| Accumulated Other Comprehensive Income | -10,617,617USD | -10,625,700USD | -10,634,714USD | -10,629,534USD | -10,628,417USD | -10,626,736USD | -10,627,379USD | -10,604,747USD |
| Total Liab | — | 5,296,646USD | 3,491,719USD | 2,681,107USD | 3,895,029USD | 4,672,161USD | 4,672,038USD | 4,946,951USD |
| Other Current Liab | — | 2,355,890USD | 2,050,690USD | 2,039,785USD | 1,971,830USD | 2,079,447USD | 2,008,735USD | 2,482,008USD |
| Capital Stock | — | 11,983USD | 8,192USD | 5,979USD | 5,752USD | 5,513USD | 5,481USD | 5,435USD |
| Other Assets | — | 1USD | — | — | — | — | — | — |
| Cash | — | 46,466,202USD | 14,599,347USD | 13,718,052USD | 16,532,199USD | 19,275,721USD | 22,849,885USD | 26,249,625USD |
| Cash And Short Term Investments | — | 46,466,202USD | 14,599,347USD | 13,718,052USD | 16,532,199USD | 19,275,721USD | 22,849,885USD | 26,249,625USD |
| Net Debt | — | -46,466,202USD | -14,599,347USD | -13,718,052USD | -16,532,199USD | -19,275,721USD | -22,849,885USD | -26,249,625USD |
| Property Plant Equipment Gross | — | 54,379USD | 153,962USD | 65,236USD | 70,665USD | 76,093USD | 153,962USD | 86,950USD |
| Common Stock Shares Outstanding | — | 7,687,961shares | 7,687,961shares | 6,372,938shares | 6,083,329shares | 5,993,866shares | 5,954,700shares | 5,939,755shares |
| Non Current Assets Total | — | 866,945USD | 372,155USD | 377,328USD | 382,500USD | 387,673USD | 403,354USD | 410,149USD |
| Non Current Liabilities Total | — | 727,361USD | 727,361USD | 727,361USD | 727,361USD | 1,311,063USD | 1,311,063USD | 1,311,063USD |
| Non Currrent Assets Other | — | 271,161USD | 312,348USD | 271,162USD | 311,835USD | 271,162USD | 281,662USD | 323,199USD |
| Net Working Capital | — | 41,948,794USD | 12,796,888USD | 11,262,881USD | 13,759,542USD | 16,473,312USD | 20,215,164USD | 22,847,932USD |
| Unclassified Equity | — | 390,346,832USD | 356,701,453USD | 353,443,596USD | 352,244,995USD | 351,140,163USD | 350,965,744USD | 350,687,968USD |
| Unclassified Non Current Liabilities | — | — | — | — | — | 1,311,063USD | 1,311,063USD | 1,311,063USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 15,933,401USD | 23,979,493USD | 22,650,174USD | 30,155,827USD | 56,823,463USD | 92,805,219USD | 133,607,885USD | 66,022,638USD |
| Other Current Assets | 961,899USD | 726,254USD | 914,275USD | 1,366,859USD | 3,508,358USD | 3,399,019USD | 2,955,878USD | 322,146USD |
| Total Liab | 3,491,719USD | 4,672,038USD | 4,385,605USD | 4,512,149USD | 7,316,499USD | 15,410,012USD | 9,364,355USD | 117,458,740USD |
| Total Stockholder Equity | 12,441,682USD | 19,307,455USD | 18,264,569USD | 25,643,678USD | 49,506,964USD | 77,395,207USD | 124,243,530USD | -51,436,102USD |
| Other Current Liab | 2,050,690USD | 2,008,735USD | 2,186,262USD | 2,358,332USD | 5,352,996USD | 10,571,237USD | 6,642,553USD | 3,128,772USD |
| Common Stock | 8,192USD | 5,481USD | 3,736USD | 2,655USD | 1,092USD | 21,187USD | 21,023USD | 127,091USD |
| Capital Stock | 8,192USD | 5,481USD | 3,736USD | 2,655USD | 21,859USD | 21,187USD | 21,023USD | 127,091USD |
| Retained Earnings | -333,641,441USD | -321,041,872USD | -308,083,161USD | -293,796,405USD | -181,134,378USD | -144,007,075USD | -90,528,263USD | -62,468,456USD |
| Cash | 14,599,347USD | 22,849,885USD | 21,606,820USD | 28,786,647USD | 53,076,052USD | 89,017,686USD | 130,088,869USD | 65,675,931USD |
| Cash And Short Term Investments | 14,599,347USD | 22,849,885USD | 21,606,820USD | 28,786,647USD | 53,076,052USD | 89,017,686USD | 130,088,869USD | 65,675,931USD |
| Total Current Assets | 15,561,246USD | 23,576,139USD | 22,521,095USD | 30,153,506USD | 56,584,410USD | 92,416,705USD | 133,044,747USD | 65,998,077USD |
| Total Current Liabilities | 2,764,358USD | 3,360,975USD | 4,385,605USD | 3,201,086USD | 7,316,499USD | 15,331,165USD | 9,061,734USD | 4,868,109USD |
| Net Debt | -14,599,347USD | -22,849,885USD | -21,606,820USD | -28,786,647USD | -52,885,581USD | -88,682,530USD | -129,543,919USD | -65,675,931USD |
| Accounts Payable | 713,668USD | 1,352,240USD | 1,670,369USD | 842,754USD | 1,773,032USD | 4,503,619USD | 2,176,852USD | 1,739,337USD |
| Property Plant Equipment Net | 59,807USD | 81,522USD | 88,362USD | 2,321USD | 209,681USD | 359,131USD | 563,031USD | 24,450USD |
| Property Plant Equipment Gross | 153,962USD | 153,962USD | 138,484USD | 2,321USD | 239,053USD | 359,131USD | 563,031USD | 24,450USD |
| Accumulated Other Comprehensive Income | -10,634,714USD | -10,627,379USD | -10,611,273USD | -10,623,408USD | -10,358,956USD | -10,037,261USD | -11,533,778USD | -8,761,325USD |
| Common Stock Shares Outstanding | 6,538,722shares | 5,509,921shares | 3,617,607shares | 82,852shares | 1,064,327shares | 1,056,682shares | 1,004,864shares | 703,783shares |
| Non Current Assets Total | 372,155USD | 403,354USD | 129,079USD | 2,321USD | 239,053USD | 388,514USD | 563,138USD | 24,561USD |
| Non Current Liabilities Total | 727,361USD | 1,311,063USD | 1,311,063USD | 1,311,063USD | 1,963,503USD | 78,847USD | 302,621USD | 112,590,631USD |
| Non Currrent Assets Other | 312,348USD | 281,662USD | 40,717USD | — | 29,372USD | 29,383USD | 107USD | 111USD |
| Net Working Capital | 12,796,888USD | 20,215,164USD | 18,135,490USD | 26,952,420USD | 49,267,911USD | 77,085,540USD | 123,983,013USD | 61,129,968USD |
| Unclassified Equity | 356,701,453USD | 350,965,744USD | 336,951,531USD | 330,058,181USD | 240,977,347USD | 231,397,169USD | 226,263,525USD | 19,539,497USD |
| Unclassified Non Current Liabilities | — | 1,311,063USD | 1,311,063USD | 1,311,063USD | 1,963,503USD | — | — | 112,590,631USD |
| Current Deferred Revenue | — | — | 528,974USD | — | — | — | — | — |
| Net Tangible Assets | — | — | — | 25,643,678USD | 49,506,964USD | 77,395,207USD | 124,243,530USD | -51,436,102USD |
| Other Assets | — | — | — | — | 29,372USD | 349,999USD | 107USD | 111USD |
| Short Term Debt | — | — | — | — | 190,471USD | 256,309USD | 242,329USD | 0USD |
| Short Long Term Debt Total | — | — | — | — | 190,471USD | 335,156USD | 544,950USD | — |
| Intangible Assets | — | — | — | — | — | — | — | 0USD |
| Deferred Long Term Liab | — | — | — | — | — | — | — | 0USD |
| Other Liab | — | — | — | — | — | — | — | 0USD |
| Good Will | — | — | — | — | — | — | — | 0USD |
| Short Long Term Debt | — | — | — | — | — | — | — | 0USD |
| Long Term Debt | — | — | — | — | — | — | — | 0USD |
| Long Term Investments | — | — | — | — | — | — | — | 0USD |
| Short Term Investments | — | — | — | — | — | — | — | 0USD |
| Inventory | — | — | — | — | — | — | — | 0USD |
| Accumulated Depreciation | — | — | — | — | — | — | — | 0USD |
| Additional Paid In Capital | — | — | — | — | — | — | — | 0USD |
| Treasury Stock | — | — | — | — | — | — | — | 0USD |
| Non Current Liabilities Other | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 11,174USD |
| Change To Liabilities | 358,429USD |
| Change In Working Capital | 502,857USD |
| Operating Cash Flow | -6,035,489USD |
| Capital Expenditures | -15,400USD |
| Investing Cash Flow | -15,400USD |
| Financing Cash Flow | 32,686,442USD |
| Effect Of Forex Changes On Cash | -1,043USD |
| Change In Cash | 26,634,510USD |
| End Cash Flow | 41,275,043USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -3,287,917USD | -2,455,630USD | -2,972,410USD | -3,238,870USD | -3,932,659USD | -2,894,799USD | -3,783,769USD | -3,470,052USD |
| Depreciation | 5,428USD | 5,429USD | 5,429USD | 5,428USD | 5,429USD | 5,428USD | 5,429USD | 5,304USD |
| Stock Based Compensation | 101,068USD | 109,024USD | 113,754USD | 136,729USD | 118,634USD | 126,028USD | 149,090USD | 128,488USD |
| Other Non Cash Items | -7,711USD | 79,072USD | 42,442USD | 29,124USD | 51,803USD | -39,185USD | 35,494USD | 5,502USD |
| Change In Working Capital | 432,406USD | -695,774USD | -338,610USD | -63,165USD | 125,630USD | -708,376USD | 1,125,454USD | -310,863USD |
| Total Cash From Operating Activities | -2,756,726USD | -3,066,902USD | -3,263,148USD | -3,130,754USD | -3,631,163USD | -3,510,904USD | -2,468,302USD | -3,641,621USD |
| Capital Expenditures | 0USD | 0USD | -1USD | 0USD | 0USD | -380USD | -209USD | -7,500USD |
| Free Cash Flow | -2,756,726USD | -3,066,900USD | -3,263,150USD | -3,130,754USD | -3,631,163USD | -3,510,904USD | -2,468,302USD | -3,649,121USD |
| Total Cash From Financing Activities | 34,624,149USD | 4,003,556USD | 370,686USD | 384,879USD | 55,849USD | 134,405USD | -1,155USD | -21,060USD |
| Issuance Of Capital Stock | 35,098,813USD | 4,213,209USD | 375,378USD | 399,785USD | 59,234USD | 140,758USD | 0USD | 0USD |
| Change In Cash | 31,867,075USD | 881,295USD | -2,814,146USD | -2,743,267USD | -3,573,916USD | -3,401,107USD | -2,444,792USD | -3,675,005USD |
| Begin Period Cash Flow | 14,640,533USD | 13,718,052USD | 16,532,198USD | 19,316,139USD | 22,890,055USD | 26,291,162USD | 28,735,954USD | 32,410,959USD |
| End Period Cash Flow | 46,507,608USD | 14,599,347USD | 13,718,052USD | 16,572,872USD | 19,316,139USD | 22,890,055USD | 26,291,162USD | 28,735,954USD |
| Other Cashflows From Financing Activities | 34,624,149USD | — | 357,940USD | -14,906USD | -3,385USD | -6,353USD | -1,155USD | -21,060USD |
| Unclassified Financing Cash Flow | -35,098,813USD | — | — | — | — | — | — | — |
| Investments | — | — | 0USD | 0USD | 0USD | 0USD | 0USD | -7,500USD |
| Total Cashflows From Investing Activities | — | — | — | — | — | 384USD | -209USD | -7,500USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -12,599,569USD | -12,958,711USD | -14,286,756USD | -112,662,027USD | -37,127,303USD | -53,478,812USD | -28,059,807USD | -15,528,269USD |
| Depreciation | 21,715USD | 22,318USD | 7,052USD | 186,445USD | 271,677USD | 229,610USD | 170,254USD | 8,316USD |
| Stock Based Compensation | 478,141USD | 489,436USD | 444,459USD | 16,981,266USD | 7,813,743USD | 4,983,023USD | 1,345,722USD | 329,184USD |
| Other Non Cash Items | 134,369USD | -54,365USD | 38,926USD | 72,241,759USD | -317,402USD | 890,252USD | -1,328,140USD | -961,316USD |
| Change In Working Capital | -929,095USD | -1,055,396USD | 1,618,711USD | -1,758,579USD | -8,326,894USD | 5,573,255USD | 1,163,264USD | 901,851USD |
| Total Cash From Operating Activities | -12,894,439USD | -13,556,718USD | -12,177,608USD | -25,011,136USD | -37,686,179USD | -41,802,672USD | -26,708,707USD | -15,250,234USD |
| Capital Expenditures | 0USD | -15,478USD | -93,093USD | 0USD | 0USD | -25,709USD | -30,901USD | -3,702USD |
| Free Cash Flow | -12,894,439USD | -13,572,196USD | -12,270,701USD | -25,011,136USD | -37,686,179USD | -41,828,381USD | -26,739,608USD | -15,253,936USD |
| Total Cash From Financing Activities | 4,640,238USD | 14,821,895USD | 5,139,990USD | 682,973USD | 1,747,012USD | 150,949USD | 92,575,538USD | 56,366,742USD |
| Issuance Of Capital Stock | 5,047,606USD | 16,140,356USD | 5,887,444USD | 682,973USD | 1,538,645USD | 86,906,179USD | 92,504,541USD | 56,364,645USD |
| Change In Cash | -8,249,522USD | 1,242,518USD | -7,139,110USD | -24,289,405USD | -35,941,634USD | -41,071,183USD | 64,412,938USD | 41,274,443USD |
| Begin Period Cash Flow | 22,890,055USD | 21,647,537USD | 28,786,647USD | 53,076,052USD | 89,017,686USD | 130,088,869USD | 65,675,931USD | 24,401,488USD |
| End Period Cash Flow | 14,640,533USD | 22,890,055USD | 21,647,537USD | 28,786,647USD | 53,076,052USD | 89,017,686USD | 130,088,869USD | 65,675,931USD |
| Other Cashflows From Financing Activities | 4,640,238USD | -1,318,461USD | -648,928USD | -69,424,194USD | 208,367USD | 150,949USD | 5,669,359USD | 56,366,742USD |
| Unclassified Financing Cash Flow | -5,047,606USD | — | — | 69,424,194USD | — | -86,906,179USD | -5,669,361USD | -56,366,740USD |
| Investments | — | -15,478USD | -85,943USD | 0USD | -16,290USD | -25,709USD | -30,901USD | -3,702USD |
| Total Cashflows From Investing Activities | — | -15,478USD | -93,093USD | — | — | -25,709USD | -30,901USD | -3,702USD |
| Change To Liabilities | — | — | — | -858,513USD | -2,730,587USD | 2,326,767USD | 437,515USD | 214,380USD |
| Sale Purchase Of Stock | — | — | — | — | — | — | 92,575,540USD | 56,366,740USD |
| Change To Account Receivables | — | — | — | — | — | — | — | 0USD |
| Change To Inventory | — | — | — | — | — | — | — | 0USD |
| Net Borrowings | — | — | — | — | — | — | — | 0USD |
| Dividends Paid | — | — | — | — | — | — | — | 0USD |
| Exchange Rate Changes | — | — | — | — | — | — | — | 0USD |
| Cash And Cash Equivalents Changes | — | — | — | — | — | — | — | 0USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.